肺段切除术与肺叶切除术治疗临床T1c影像学纯实性非小细胞肺癌的肿瘤学结局比较
该回顾性研究比较了肺段切除术与肺叶切除术在临床T1c(>2-3 cm)影像学纯实性非小细胞肺癌中的生存结局、死亡原因和复发模式。共纳入426例患者,其中肺叶切除术381例,肺段切除术45例,中位随访53个月。多变量分析显示肺叶切除术是更好总生存的独立预后因素(HR 0.596,95%CI 0.366-0.969;P=0.037),肺叶切除组5年总生存率和无复发生存率均优于肺段切除组,且肺段切除组5年局部区域复发累积发生率显著更高(35.5% vs 15.8%,P<0.001)。结论认为在T1c影像学纯实性非小细胞肺癌中,肺段切除术与更差的生存和局部区域肿瘤控制不足显著相关,肺叶切除术仍是标准手术治疗,肺段切除术应极为谨慎地应用。
要点
- 肺叶切除术是更好总生存的独立预后因素(HR 0.596,95%CI 0.366-0.969;P=0.037)。
- 肺叶切除组5年总生存率72.9% vs 肺段切除组59.7%(P=0.007)。
- 肺段切除组5年局部区域复发累积发生率35.5% vs 肺叶切除组15.8%(P<0.001)。
核心结论
- 在T1c影像学纯实性非小细胞肺癌中,肺段切除术与更差的生存和局部区域肿瘤控制不足显著相关;肺叶切除术仍是标准手术治疗,而肺段切除术应极为谨慎地应用。
研究设计与样本
- 回顾性研究,比较肺段切除术与肺叶切除术在c-T1cN0M0影像学纯实性非小细胞肺癌患者中的生存结局、死亡原因和复发模式,共纳入426例患者,其中肺叶切除术381例,肺段切除术45例,中位随访53个月。
主要发现
- 426例患者中,104例(24.4%)发现淋巴结转移。
- 多变量分析显示肺叶切除术是更好总生存的独立预后因素(HR 0.596,95%CI 0.366-0.969;P=0.037)。
- 肺叶切除组5年总生存率72.9% vs 肺段切除组59.7%(log-rank检验P=0.007);5年无复发生存率64.4% vs 48.7%(P=0.034)。
- 肺叶切除组约14%的患者死于肺癌,肺段切除组约27%的患者死于肺癌。
- 肺段切除组5年局部区域复发累积发生率显著高于肺叶切除组(35.5% vs 15.8%,P<0.001)。
临床怎么用
- 作者认为肺叶切除术仍是T1c影像学纯实性非小细胞肺癌的标准手术治疗,肺段切除术应极为谨慎地应用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to compare the outcomes of segmentectomy with those of lobectomy in T1c (>2-3 cm) radiological pure-solid non-small-cell lung cancer detected on thin-section computed tomography. METHODS: This retrospective review compared the survival outcomes, causes of death and recurrence patterns between the segmentectomy and lobectomy in patients with c-T1cN0M0 radiological pure-solid non-small-cell lung cancer. Multivariable analysis was performed to control for confounders of survival. The overall survival (OS) and recurrence-free survival were analysed using the Kaplan-Meier method. Differences in cumulative incidence of recurrence between groups were assessed using the methods of Gray. RESULTS: Of the 426 patients, lobectomy was performed in 381 patients and segmentectomy in 45 patients. Nodal metastasis was noted in 104 (24.4%) patients. Multivariable analysis revealed that lobectomy was an independent prognosticator of better OS (hazard ratio 0.596, 95% confidence interval 0.366-0.969; P = 0.037). Lobectomy arm showed favourable 5-year OS and recurrence-free survival (OS: 72.9% vs 59.7%, log-rank test P = 0.007; recurrence-free survival: 64.4% vs 48.7%, P = 0.034) (median follow-up: 53 months). Approximately 14% of the patients in the lobectomy group and 27% in the segmentectomy group died of lung cancer. Furthermore, 5-year cumulative incidence of loco-regional recurrence rate was significantly higher in the segmentectomy group (35.5% vs 15.8%, P < 0.001). CONCLUSIONS: In T1c radiological pure-solid non-small-cell lung cancer, segmentectomy was significantly associated with worse survival and insufficient loco-regional cancer control. Lobectomy remains the standard surgical treatment; meanwhile, segmentectomy should be applied with great caution.
引用
- Hattori A, Takamochi K, Matsunaga T, et al. Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37738593. doi:10.1093/icvts/ivad152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。